Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Todd Neale

February 14, 2025

Presentation THT 2024

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Presenter: Kanika P. Mody

March 06, 2024

Presentation THT 2024

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Cardiogenic Shock: The Case for Feasibility and Recovery

Presenter: Aasim Afzal

March 04, 2024

Presentation THT 2024

Unloading Effect of Intra-aortic balloon pump and Impella in Venoarterial ECMO Patients

Presenter: Fouad Sakr

March 04, 2024

Presentation THT 2024

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

Advertisement

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Cardiogenic Shock: The Case for Feasibility and Recovery

Unloading Effect of Intra-aortic balloon pump and Impella in Venoarterial ECMO Patients

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content